Zolinza with bortezomib provide preliminary anti-tumor activity

Armen Hareyan's picture
Advertisement

Studies of patients with advanced multiple myeloma show that Zolinza with bortezomib provide preliminary anti-tumor activity.

Results from two investigational Phase I trials of ZOLINZA

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.
Advertisement